All Stories

  1. Light-Triggered Gold Nanoparticles Remodel Tumor Architecture to Enhance Drug Penetration
  2. Association of Interleukin 1 Receptor Antagonist (IL1RN) rs4251961 with Periodontitis Risk in Portuguese Postpartum Women: A Pilot Study
  3. Modulating PhpC bioavailability and cellular activity in lung cancer cells via gold nanoparticle functionalization
  4. From 2D to 3D Colorectal Cancer Patient-Derived Organoids (PDOs) and In Vivo Models: Copper(II) Complexes as Promising New Antitumor Agents
  5. Synthesis and Biological Activity of Novel Aromatic Aminopropyl Lactams in Two Cancer Cell Models
  6. Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab
  7. Making Room at the Nanoscale: A Tangible Perspective on Surface Crowding and Molecular Design
  8. Correction: Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells
  9. Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells
  10. 2D and 3D antiproliferative properties of Schiff base and reduced Schiff base palladium( ii ) complexes in doxorubicin-resistant colorectal cancer cells
  11. miRNA-155-3p and miRNA-3196 as Potential Biomarkers in Liquid Biopsies of Non-Small Cell Lung Cancer Patients
  12. Therapeutic Potential of 2,2′:6′,2″-Terpyridine-Based Au(III), Pt(II), and Mn(II) Complexes against 2D and 3D Human Colorectal Resistant Cancer Cells
  13. Shared Inflammatory Genetic Susceptibility Underlying Spontaneous Preterm Birth and Periodontitis: A Case–Control Study
  14. Heat up, silence on: IDO1 gene silencing in THP-1-derived dendritic cells triggered by magnetic hyperthermia
  15. Cellular modulation of a G-quadruplex structure found in the lung cancer-related microRNA-3196
  16. Cytocompatibility, fibroblast adhesion and proliferation on surface modified 3D-printed PEEK scaffolds
  17. KCNN3genetic variants rs1218585 and rs1218584 are associated with spontaneous preterm birth in a Portuguese population
  18. Mechanistic Insights of a p53-Targeting Small Molecule
  19. Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy
  20. Correction: Membrane-localized magnetic hyperthermia promotes intracellular delivery of cell-impermeant probes
  21. Synthesis, characterization and biological activity of methotrexate-derived salts in lung cancer cells
  22. Photoactivated bioinspired lipoplexes with a chalcone/flavylium photoswitch enhance siRNA delivery—towards precise spatiotemporal control in gene delivery
  23. Breaking the mold: 3D cell cultures reshaping the future of cancer research
  24. Shrinking Cancer Research Barriers: Crafting Accessible Tumor‐on‐Chip Device for Gene Silencing Assays
  25. Optimization of Antiproliferative Properties of Triimine Copper(II) Complexes
  26. Bringing Hope to Improve Treatment in Pancreatic Ductal Adenocarcinoma—A New Tool for Molecular Profiling of KRAS Mutations in Tumor and Plasma Samples
  27. Detecting mir-155-3p through a Molecular Beacon Bead-Based Assay
  28. Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line
  29. Discovery of novel fluorescent azaindoles with cytotoxic action in A2780 ovarian carcinoma cells
  30. Mild hyperthermia via gold nanoparticles and visible light irradiation for enhanced siRNA and ASO delivery in 2D and 3D tumour spheroids
  31. Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ–Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models
  32. Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents
  33. Anti-inflammatory and antiproliferative activity of Helichrysum odoratissimum Sweet. against lung cancer
  34. Assessing the gene silencing potential of AuNP-based approaches on conventional 2D cell culture versus 3D tumor spheroid
  35. Effect of mono- and dinuclear thiosemicarbazone platinacycles in the proliferation of a colorectal carcinoma cell line
  36. Membrane-localized magnetic hyperthermia promotes intracellular delivery of cell-impermeant probes
  37. Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation
  38. Antimicrobial Activity of Manganese(I) Tricarbonyl Complexes Bearing 1,2,3-Triazole Ligands
  39. Tackling Imatinib Resistance via Au‐nanoconjugates using A Cml Resistant Cell Line
  40. Half-sandwich Ru(II) N-heterocyclic carbene complexes in anticancer drug design
  41. Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
  42. In Vitro and In Vivo Biological Activities of Dipicolinate Oxovanadium(IV) Complexes
  43. Hybrid Digital-Droplet Microfluidic Chip for Applications in Droplet Digital Nucleic Acid Amplification: Design, Fabrication and Characterization
  44. Parylene C as a Multipurpose Material for Electronics and Microfluidics
  45. Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples
  46. Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo
  47. Cell Uptake of Steroid-BODIPY Conjugates and Their Internalization Mechanisms: Cancer Theranostic Dyes
  48. Open-source tool for real-time and automated analysis of droplet-based microfluidic
  49. Short Lecture 4 “Evaluation of antiproliferative and anti-angiogenic activity of an ethanolic extract of Helichrysum odoratissimum (L.) Sweet against skin cancer”
  50. Antiproliferative Activity of Buddleja saligna (Willd.) against Melanoma and In Vivo Modulation of Angiogenesis
  51. In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes
  52. Editorial: Rational drug design of metal complexes for cancer therapy
  53. Engineering gold nanoparticles for molecular diagnostics and biosensing
  54. Digital Microfluidics for Amplification Monitoring of Cancer Biomarkers
  55. Digital Microfluidics-Powered Real-Time Monitoring of Isothermal DNA Amplification of Cancer Biomarker
  56. Endogenous Fluorescent Proteins in the Mucus of an Intertidal Polychaeta: Clues for Biotechnology
  57. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer
  58. Light Triggered Enhancement of Antibiotic Efficacy in Biofilm Elimination Mediated by Gold-Silver Alloy Nanoparticles
  59. A solvent‐free strategy to prepare amorphous salts of folic acid with enhanced solubility and cell permeability
  60. Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
  61. Boron clusters (ferrabisdicarbollides) shaping the future as radiosensitizers for multimodal (chemo/radio/PBFR) therapy of glioblastoma
  62. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
  63. Aggregation versus Biological Activity in Gold(I) Complexes. An Unexplored Concept
  64. New Non-Toxic N-alkyl Cholinium-Based Ionic Liquids as Excipients to Improve the Solubility of Poorly Water-Soluble Drugs
  65. Manganese(I) tricarbonyl complexes as potential anticancer agents
  66. Vanadium(IV) Complexes with Methyl-Substituted 8-Hydroxyquinolines: Catalytic Potential in the Oxidation of Hydrocarbons and Alcohols with Peroxides and Biological Activity
  67. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2′:6′,2″-terpyridine ligands: From in vitro to in vivo biological properties
  68. Inflammatory factors, genetic variants , and predisposition for preterm birth
  69. Genetic predisposition for aggressive behaviour related with dopamine and serotonin pathways – an overview
  70. The genetic susceptibility linking preterm birth and periodontal disease – a review
  71. Liposomal Nanosystems in Rheumatoid Arthritis
  72. Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury
  73. In Vitro and In Vivo Effect of Palladacycles: Targeting A2780 Ovarian Carcinoma Cells and Modulation of Angiogenesis
  74. Rosa x hybrida extracts with dual actions: Antiproliferative effects against tumour cells and inhibitor of Alzheimer disease
  75. Combined cancer therapeutics—Tackling the complexity of the tumor microenvironment
  76. A Transcriptomic Approach to the Recruitment of Venom Proteins in a Marine Annelid
  77. Specific Antiproliferative Properties of Proteinaceous Toxin Secretions from the Marine Annelid Eulalia sp. onto Ovarian Cancer Cells
  78. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line
  79. Cu(i) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action
  80. Benchtop X-ray fluorescence imaging as a tool to study gold nanoparticle penetration in 3D cancer spheroids
  81. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities
  82. Water safety screening via multiplex LAMP-Au-nanoprobe integrated approach
  83. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  84. Hyperthermia Induced by Gold Nanoparticles and Visible Light Photothermy Combined with Chemotherapy to Tackle Doxorubicin Sensitive and Resistant Colorectal Tumor 3D Spheroids
  85. Tackling Multidrug Resistance in Streptococci – From Novel Biotherapeutic Strategies to Nanomedicines
  86. The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment
  87. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
  88. Nanotheranostics in Gene Therapy
  89. Synthesis of new hetero-arylidene-9(10H)-anthrone derivatives and their biological evaluation
  90. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  91. Fast Prototyping Microfluidics: Integrating Droplet Digital Lamp for Absolute Quantification of Cancer Biomarkers
  92. Gene Therapy in Cancer Treatment: Why Go Nano?
  93. Size-Dependent Biological Activities of Fluorescent Organosilane-Modified Zinc Oxide Nanoparticles
  94. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes
  95. Improving the Anti-inflammatory Response via Gold Nanoparticle Vectorization of CO-Releasing Molecules
  96. RNA Quantification Using Noble Metal Nanoprobes: Simultaneous Identification of Several Different mRNA Targets Using Color Multiplexing and Application to Chronic Myeloid Leukemia Diagnostics
  97. Paper-Based SERS Platform for One-Step Screening of Tetracycline in Milk
  98. Light Irradiation of Gold Nanoparticles Toward Advanced Cancer Therapeutics
  99. Cation-mediated gelation of the fucose-rich polysaccharide FucoPol: preparation and characterization of hydrogel beads and their cytotoxicity assessment
  100. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles
  101. Antiproliferative activity of heterometallic sodium and potassium-dioxidovanadium(V) polymers
  102. Structural characterization and biological properties of silver(I) tris(pyrazolyl)methane sulfonate
  103. Nanotheranostics Targeting the Tumor Microenvironment
  104. Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles
  105. Occurrence of non-toxic bioemulsifiers during polyhydroxyalkanoate production by Pseudomonas strains valorizing crude glycerol by-product
  106. Ionic Liquids and Salts from Ibuprofen as Promising Innovative Formulations of an Old Drug
  107. Structural aspects of a trimetallic CuII derivative: cytotoxicity and anti-proliferative activity on human cancer cell lines
  108. Enhancement of water solubility of poorly water-soluble drugs by new biocompatible N-acetyl amino acid N-alkyl cholinium-based ionic liquids
  109. New lessons from ancient life: marine invertebrates as a source of new drugs
  110. Targeting Tumor Microenvironment for Cancer Therapy
  111. GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach
  112. Antibody modified gold nanoparticles for fast colorimetric screening of rheumatoid arthritis
  113. A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
  114. Front Cover: The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes (Chem. Eur. J. 55/2018)
  115. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  116. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  117. Cover Feature: POxylated Dendrimer-Based Nano-in-Micro Dry Powder Formulations for Inhalation Chemotherapy (ChemistryOpen 10/2018)
  118. A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms
  119. Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells
  120. Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics: an update
  121. POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
  122. Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
  123. Evaluation of cell toxicity and DNA and protein binding of green synthesized silver nanoparticles
  124. Optical and Structural Characterization of a Chronic Myeloid Leukemia DNA Biosensor
  125. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells
  126. Synthesis, Cytotoxicity Evaluation in Human Cell Lines and in Vitro DNA Interaction of a Hetero‐Arylidene‐9(10H)‐Anthrone
  127. Multifunctional microfluidic chip for optical nanoprobe based RNA detection – application to Chronic Myeloid Leukemia
  128. Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
  129. Allele specific LAMP- gold nanoparticle for characterization of single nucleotide polymorphisms
  130. Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles
  131. A Digital Microfluidics Platform for Loop-Mediated Isothermal Amplification Detection
  132. Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles
  133. Digital Microfluidics for Nucleic Acid Amplification
  134. Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
  135. Quantitative real-time monitoring of RCA amplification of cancer biomarkers mediated by a flexible ion sensitive platform
  136. Smuggling gold nanoparticles across cell types – A new role for exosomes in gene silencing
  137. Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?
  138. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
  139. Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy
  140. Gold Nanobeacons for Tracking Gene Silencing in Zebrafish
  141. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents
  142. Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy
  143. Gold Nanoparticles in Molecular Diagnostics and Molecular Therapeutics
  144. Current trends in molecular diagnostics of chronic myeloid leukemia
  145. Gold Nanoparticles for Diagnostics: Advances towards Points of Care
  146. Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo
  147. Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
  148. BioCode gold-nanobeacon for the detection of fusion transcripts causing chronic myeloid leukemia
  149. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT
  150. Infection of human keratinocytes by Streptococcus dysgalactiae subspecies dysgalactiae isolated from milk of the bovine udder
  151. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy
  152. Synthesis, characterization, thermal properties and antiproliferative potential of copper(ii) 4′-phenyl-terpyridine compounds
  153. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
  154. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos
  155. A novel mutation inCEBPAgene in a patient with acute myeloid leukemia
  156. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
  157. Scalable approach for the production of functional DNA based gold nanoprobes
  158. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
  159. Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles
  160. Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics
  161. One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care
  162. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects
  163. 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  164. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine
  165. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
  166. Field Effect Sensors for Nucleic Acid Detection: Recent Advances and Future Perspectives
  167. Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial
  168. Nanoparticles for Diagnostics and Imaging
  169. DNA adduct identification using gold-aptamer nanoprobes
  170. Single nucleotide polymorphism detection using gold nanoprobes and bio-microfluidic platform with embedded microlenses
  171. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing
  172. Mobile Based Gold Nanoprobe TB Diagnostics for Point-of-Need
  173. Characterization of genomic single nucleotide polymorphism via colorimetric detection using a single gold nanoprobe
  174. Metabolic and histopathological alterations in the marine bivalve Mytilus galloprovincialis induced by chronic exposure to acrylamide
  175. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles
  176. Gold nanobeacons: a potential nanotheranostics platform
  177. A promising road with challenges: where are gold nanoparticles in translational research?
  178. Cancer therapy
  179. AuNPs for identification of molecular signatures of resistance
  180. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
  181. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
  182. Dual-color control of nucleotide polymerization sensed by a fluorescence actuator
  183. Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis
  184. A low cost, safe, disposable, rapid and self-sustainable paper-based platform for diagnostic testing: lab-on-paper
  185. Ion sensing (EIS) real-time quantitative monitorization of isothermal DNA amplification
  186. Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies
  187. Star-shaped magnetite@gold nanoparticles for protein magnetic separation and SERS detection
  188. Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells
  189. Histopathological findings onCarassius auratushepatopancreas upon exposure to acrylamide: correlation with genotoxicity and metabolic alterations
  190. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models
  191. Coupling an universal primer to SBE combined spectral codification strategy for single nucleotide polymorphism analysis
  192. Bio-microfluidic platform for gold nanoprobe based DNA detection—application to Mycobacterium tuberculosis
  193. THE CHEMISTRY AND BIOLOGY OF GOLD NANOPARTICLE-MEDIATED PHOTOTHERMAL THERAPY: PROMISES AND CHALLENGES
  194. Association of FTO and PPARG polymorphisms with obesity in Portuguese women
  195. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
  196. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events
  197. Fast nucleotide identification through fingerprinting using gold nanoparticle-based surface-assisted laser desorption/ionisation
  198. Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
  199. Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis
  200. Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles
  201. Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
  202. Could gold nanoprobes be an important tool in cancer diagnostics?
  203. Gold-nanobeacons for real-time monitoring of RNA synthesis
  204. Gold and silver nanoparticles for clinical diagnostics — From genomics to proteomics
  205. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles
  206. Enhancement of antibiotic effect via gold:silver-alloy nanoparticles
  207. Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
  208. RNA Quantification with Gold Nanoprobes for Cancer Diagnostics
  209. Noble Metal Nanoparticles for Biosensing Applications
  210. Gold on paper–paper platform for Au-nanoprobe TB detection
  211. RNA Quantification Using Noble Metal Nanoprobes: Simultaneous Identification of Several Different mRNA Targets Using Color Multiplexing and Application to Cancer Diagnostics
  212. Noble Metal Nanoparticles Applications in Cancer
  213. Nanophotonics for Molecular Diagnostics and Therapy Applications
  214. Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection
  215. Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta2O5 electrolyte–insulator–semiconductor sensor
  216. Experimental photophysical characterization of fluorophores in the vicinity of gold nanoparticles
  217. Coupling single base extension to a spectral codification tool for increased throughput screening
  218. Alloy metal nanoparticles for multicolor cancer diagnostics
  219. Portable optoelectronic biosensing platform for identification of mycobacteria from the Mycobacterium tuberculosis complex
  220. Nanoparticles in Molecular Diagnostics
  221. pH Effect on the Photochemistry of 4-Methylcoumarin Phosphate Esters: Caged-Phosphate Case Study
  222. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles
  223. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis
  224. Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex
  225. New insights into the use of magnetic force microscopy to discriminate between magnetic and nonmagnetic nanoparticles
  226. Use of cyclodextrins as scavengers of inhibitory photo-products in light controlled in vitro synthesis of RNA
  227. Gold–silver-alloy nanoprobes for one-pot multiplex DNA detection
  228. Development of a fast and efficient ultrasonic-based strategy for DNA fragmentation
  229. Optimizing Au-nanoprobes for specific sequence discrimination
  230. Inkjet printed and “doctor blade” TiO2 photodetectors for DNA biosensors
  231. RNA quantification using gold nanoprobes - application to cancer diagnostics
  232. Gold nanoprobes assay for identification of mycobacteria from theMycobacterium tuberculosiscomplex
  233. General FRET-based coding for application in multiplexing methods
  234. Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
  235. Multiplexed spectral coding for simultaneous detection of DNA hybridization reactions based on FRET
  236. Light activation of transcription: photocaging of nucleotides for control over RNA polymerization
  237. Characterization of optoelectronic platform using an amorphous/nanocrystalline silicon biosensor for the specific identification of nucleic acid sequences based on gold nanoparticle probes
  238. Identification of unamplified genomic DNA sequences using gold nanoparticle probes and a novel thin film photodetector
  239. Gold nanoparticles for the development of clinical diagnosis methods
  240. Imaging Gold Nanoparticles for DNA Sequence Recognition in Biomedical Applications
  241. Gold Nanoparticle Based Systems in Genetics
  242. Amorphous/nanocrystalline silicon biosensor for the specific identification of unamplified nucleic acid sequences using gold nanoparticle probes
  243. Novel Optoelectronic Platform using an Amorphous/Nanocrystalline Silicon Biosensor for the Specific Identification of Unamplified Nucleic Acid Sequences Based on Gold Nanoparticle Probes
  244. Nanodiagnostics: fast colorimetric method for single nucleotide polymorphism/mutation detection
  245. Gold-Nanoparticle-Probe–Based Assay for Rapid and Direct Detection of Mycobacterium tuberculosis DNA in Clinical Samples
  246. Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles
  247. Principles in genetic risk assessment
  248. Construction and Analysis of a Sequence-Ready Map in 4q25: Rieger Syndrome Can Be Caused by Haploinsufficiency ofRIEG, but Also by Chromosome Breaks ≈90 kb Upstream of This Gene